학술논문
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
Document Type
Article
Author
Source
In Journal of Clinical Lipidology January-February 2020 14(1):77-87
Subject
Language
ISSN
1933-2874